Skip to main content

Table 1 Average OTM values of the different cell types at the different treatment times with CAP

From: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro study

Cell Line

30 s

60 s

90 s

120 s

180 s

Cal 27

1.32

3.07

2.78

2.95

4.78

FaDu

1.64

3.03

6.87

9.28

10.60

OSC 19

1.48

3.05

4.82

6.11

7.69

Back to article page

Head & Face Medicine

ISSN: 1746-160X

Contact us